Rac-Vigabatrin-13C,d2 (Major) is a labeled form of vigabatrin, a medication primarily used in the treatment of epilepsy, particularly for refractory complex partial seizures. The designation "rac" indicates that the substance is a racemic mixture, containing equal amounts of two enantiomers. The "13C" signifies that the compound is isotopically enriched with carbon-13, which is often used in research and analytical applications to trace metabolic pathways or study pharmacokinetics. The "d2" indicates the presence of deuterium, a stable isotope of hydrogen, which can enhance the sensitivity of nuclear magnetic resonance (NMR) spectroscopy and other analytical techniques. This compound's unique isotopic labeling allows for detailed studies of its behavior in biological systems, including absorption, distribution, metabolism, and excretion. Overall, rac-Vigabatrin-13C,d2 serves as a valuable tool in both clinical and research settings, providing insights into the pharmacological properties of vigabatrin and its interactions within the body.

rac-Vigabatrin-13C,d2  (Major)

1330171-61-3: Rac-Vigabatrin-13C,d2 (Major) is a labeled form of vigabatrin, a medication primarily used in the treatment of epilepsy, particularly for refractory complex partial seizures. The designation "rac" indicates that the substance is a racemic mixture, containing equal amounts of two enantiomers. The "13C" signifies that the compound is isotopically enriched with carbon-13, which is often used in research and analytical applications to trace metabolic pathways or study pharmacokinetics. The "d2" indicates the presence of deuterium, a stable isotope of hydrogen, which can enhance the sensitivity of nuclear magnetic resonance (NMR) spectroscopy and other analytical techniques. This compound's unique isotopic labeling allows for detailed studies of its behavior in biological systems, including absorption, distribution, metabolism, and excretion. Overall, rac-Vigabatrin-13C,d2 serves as a valuable tool in both clinical and research settings, providing insights into the pharmacological properties of vigabatrin and its interactions within the body.

Stability Hygroscopic Applications Labelled Vigabatrin. A novel antiepileptic drug. Antidepressant; antipsychotic; anxiolytic. References Vajda, F., et al.: Clin. Neurosci., 7, 88 (2000), Beghi, E., et al.: Lancet. Neurol., 3, 618 (2004), Sagirli, O., et al.: J. Pharmaceut. Biomed., 42, 618 (2006),

CAS 1330171-61-3

rac-Vigabatrin-13C,d2 (Major)

rac-Vigabatrin-13C,d2 (Major)

Ref: TR-V253002